Mosliciguat, an experimental treatment being developed by Pulmovant, was more effective than a placebo at improving blood ...

People often say things to others who are living with chronic illness that lack empathy and understanding, writes columnist.

People with pulmonary arterial hypertension and their caregivers can register now for an upcoming PAH Initiative broadcast on ...

The TAPSE/sPAP heart imaging metric closely mirrors daily PAH symptoms, giving doctors an objective tool to track disease ...

Keeping a personal record of her symptoms, mood, and appointments gives columnist Anna Jeter a sense of ownership over her health.

Tell us a little about yourself and your experience with pulmonary hypertension. Your answers help us share information, resources, and community content that are more relevant to you. It only takes ...

Mike Naple (he/him) lives in Washington, D.C., but calls San Diego, California, home. Mike was diagnosed with pulmonary hypertension in 2016. He also manages living with interstitial lung disease, ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

A committee of the European Medicines Agency (EMA) has recommended that Yuvanci, a tablet containing macitentan and tadalafil, be approved for pulmonary arterial hypertension (PAH). The positive ...

Soon after Yutrepia (treprostinil) was approved by the U.S. Food and Drug Administration (FDA) to treat some forms of pulmonary hypertension, the therapy’s maker, Liquidia, scheduled its first ...

Pulmonary hypertension (PH) is a rare but severe health condition characterized by high blood pressure in the pulmonary arteries. It is diagnosed when the arteries that transport blood from the heart ...